Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Director · Chief Executive Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 9,140,510 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 318,806 · Balance 9,140,510 F1: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:12 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 318,806 | $4.19 | $1,335,797.14 |
DisclosureSEC source: 0001801170-26-000242 · wk-form4_1790971970.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,140,510 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 22:30 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 87,798 | $4.65 | $408,260.70 |
DisclosureSEC source: 0001838733-26-000028 · wk-form4_1786401005.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,459,316 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting on August 8, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on August 8, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 62,711 | $4.67 | $292,860.37 |
DisclosureSEC source: 0001801170-26-000179 · wk-form4_1784235556.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,547,114 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 22:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 313,476 | $5.32 | $1,667,692.32 |
DisclosureSEC source: 0001838733-26-000015 · wk-form4_1782945186.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,609,825 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,704 | $2.82 | $241,685.28 |
DisclosureSEC source: 0001801170-26-000123 · wk-form4_1778617015.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,923,301 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:13 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 60,765 | $2.04 | $123,960.60 |
DisclosureSEC source: 0001838733-26-000012 · wk-form4_1776370406.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,009,005 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:31 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 309,558 | $1.76 | $544,822.08 |
DisclosureSEC source: 0001838733-26-000011 · wk-form4_1775248272.xml · nonDerivative · entry 2 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,069,770 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 1, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:31 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 956,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001838733-26-000011 · wk-form4_1775248272.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,379,328 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 21:56 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,704 | $2.13 | $182,549.52 |
DisclosureSEC source: 0001838733-26-000007 · wk-form4_1770760598.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,423,021 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 00:28 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 60,764 | $2.81 | $170,746.84 |
DisclosureSEC source: 0001801170-26-000028 · wk-form4_1768955327.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,508,725 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:27 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 267,958 | $2.35 | $629,701.30 |
DisclosureSEC source: 0001838733-26-000003 · wk-form4_1767655651.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,569,489 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 08, 2025 Filed Nov 12, 2025 21:02 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,535 | $2.67 | $228,378.45 |
DisclosureSEC source: 0001838733-25-000011 · wk-form4_1762981363.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,837,447 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:49 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 242,580 | $2.80 | $679,224.00 |
DisclosureSEC source: 0001838733-25-000008 · wk-form4_1760734185.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,922,982 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:10 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 308,950 | $2.62 | $809,449.00 |
DisclosureSEC source: 0001801170-25-000239 · wk-form4_1759522212.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,165,562 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:47 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,535 | $2.18 | $186,466.30 |
DisclosureSEC source: 0001801170-25-000219 · wk-form4_1755031617.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,474,512 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 20:21 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 308,950 | $2.75 | $849,612.50 |
DisclosureSEC source: 0001801170-25-000166 · wk-form4_1751574092.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,560,047 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on July 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:31 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,535 | $3.75 | $320,756.25 |
DisclosureSEC source: 0001801170-25-000135 · wk-form4_1747081892.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,868,997 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:34 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 308,950 | $3.59 | $1,109,130.50 |
DisclosureSEC source: 0001801170-25-000077 · wk-form4_1743712443.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,954,532 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 21:19 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,535 | $4.32 | $369,511.20 |
DisclosureSEC source: 0001801170-25-000041 · wk-form4_1739308770.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,263,482 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:20 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 278,765 | $3.15 | $878,109.75 |
DisclosureSEC source: 0001801170-25-000003 · wk-form4_1735939220.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,349,017 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 21:23 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,367 | $3.41 | $291,101.47 |
DisclosureSEC source: 0001801170-24-000236 · wk-form4_1731446592.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,627,782 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 1,910,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000211 · wk-form4_1729196186.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,713,149 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 21:08 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 308,341 | $2.78 | $857,187.98 |
DisclosureSEC source: 0001801170-24-000197 · wk-form4_1727903310.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,802,321 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 1, 2024, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:34 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,367 | $1.83 | $156,221.61 |
DisclosureSEC source: 0001801170-24-000167 · wk-form4_1723494878.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,110,662 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 8, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:06 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 308,341 | $1.20 | $370,009.20 |
DisclosureSEC source: 0001801170-24-000147 · wk-form4_1720037158.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,196,029 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on July 1, 2024, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,367 | $0.87 | $74,269.29 |
DisclosureSEC source: 0001801170-24-000106 · wk-form4_1715371740.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,504,370 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:12 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 308,341 | $0.77 | $237,422.57 |
DisclosureSEC source: 0001801170-24-000080 · wk-form4_1712175139.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,589,737 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 1, 2024, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 20:51 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,367 | $1.00 | $85,367.00 |
DisclosureSEC source: 0001801170-24-000055 · wk-form4_1707771101.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,898,078 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:34 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 1,084,906 | $0.95 | $1,030,660.70 |
DisclosureSEC source: 0001801170-24-000014 · wk-form4_1704317640.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,983,445 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2024, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 21:19 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 83,514 | $0.90 | $75,162.60 |
DisclosureSEC source: 0001801170-23-000108 · wk-form4_1699910340.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,068,351 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 20:46 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 277,720 | $1.33 | $369,367.60 |
DisclosureSEC source: 0000895345-23-000452 · form4.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,151,865 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 8, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after August 8, 2023, in each case subject to the continued service of the Reporting Person on such vesting date. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:01 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 9,734,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000265 · wf-form4_167286964219043.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,429,585 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 1, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 1, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 2,695,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-022231 · wf-form4_166016358247135.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,695,072 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of August 8, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 8, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantPerformance-based Restricted Stock Units · Derivative | 11,142,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 6 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,142,328 Underlying: Class B Common Stock · 11,142,328 shares Expires not disclosed F9 · derivative.exercise_price: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F9 · derivative.exercise_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F9 · derivative.expiration_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantPerformance-based Restricted Stock Units · Derivative | 3,582,291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 5 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,582,291 Underlying: Class B Common Stock · 3,582,291 shares Expires not disclosed F9 · derivative.exercise_price: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F10 · price: Received in connection with the Business Combination in exchange for restricted stock units that will have settled for 1,732,187 shares of common stock of Legacy Clover. F9 · derivative.exercise_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F9 · derivative.expiration_date: Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantStock Options (right to buy) · Derivative | 3,669,607 | Not disclosed Strike: $5.45 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 4 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669,607 Underlying: Class B Common Stock · 3,669,607 shares Expires 2030-02-03 F8 · price: Received in connection with the Business Combination in exchange for options to acquire 1,774,408 shares of common stock of Legacy Clover for $11.27 per share. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantStock Options (right to buy) · Derivative | 5,334,515 | Not disclosed Strike: $2.23 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 3 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,334,515 Underlying: Class B Common Stock · 5,334,515 shares Expires 2030-02-03 F7 · price: Received in connection with the Business Combination in exchange for options to acquire 2,579,460 shares of common stock of Legacy Clover for $4.61 per share. F6 · derivative.exercise_date: The option vested as to 1/60th of the total number of shares on July 1, 2019, and thereafter vested and shall continue to vest as to 1/60th of the total number of shares in equal monthly installments. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantStock Options (right to buy) · Derivative | 3,155,168 | Not disclosed Strike: $1.67 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 2 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,155,168 Underlying: Class B Common Stock · 3,155,168 shares Expires 2028-07-21 F5 · price: Received in connection with the Business Combination in exchange for options to acquire 1,525,655 shares of common stock of Legacy Clover for $3.45 per share. F4 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on February 5, 2019 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantStock Options (right to buy) · Derivative | 631,033 | Not disclosed Strike: $1.67 | Not disclosed |
DisclosureSEC source: 0001209191-21-003164 · doc4.xml · derivative · entry 1 Toy Andrew · CIK 0001838733 · Director · President and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,033 Underlying: Class B Common Stock · 631,033 shares Expires 2028-07-21 F3 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for options to acquire 305,131 shares of common stock of Legacy Clover for $3.45 per share. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.